These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 353752)

  • 1. The methanol extract residue (MER) of bacillus calmette-guerin in cancer immunotherapy.
    Domenick NP
    Nurs Clin North Am; 1978 Jun; 13(2):369-80. PubMed ID: 353752
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of methanol extraction residue of Bacillus calmette-Guérin in humans.
    Perloff M; Holland JF; Lumb GJ; Bekesi JG
    Cancer Res; 1977 Apr; 37(4):1191-6. PubMed ID: 321117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methanol extraction residue fraction of tubercle bacilli (MER) and other mycobacterial extracts as systemic immunity adjuvants in cancer immunotherapy.
    Mathé G; Hiu IJ; Halle-Pannenko O; Bourut C
    Isr J Med Sci; 1976; 12(4-5):468-71. PubMed ID: 820673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer.
    Moertel CG; Ritts RE; Schutt AJ; Hahn RG
    Cancer Res; 1975 Nov; 35(11 Pt 1):3075-83. PubMed ID: 1102082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A technique for intensifying BCG sensitivity.
    Parmett SR; Klein E
    J Med; 1975; 6(3-4):213-6. PubMed ID: 1104733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus Calmette-Guérin and antilymphocyte serum in carcinogenesis. Effects on the hamster pouch.
    Giunta JL; Reif AE; Shklar G
    Arch Pathol; 1974 Oct; 98(4):237-40. PubMed ID: 4606260
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase I study of immunotherapy with methanol extraction residue (MER) of bacillus Calmette-Guérin.
    Richman SP; Gutterman JU; Hersh EM; Burgess MA; Mavligit GM
    Cancer Treat Rep; 1977; 61(3):471-2. PubMed ID: 872144
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of methanol extraction residue and therapeutic irradiation against established isografts and simulated local recurrence of mammary carcinomas.
    Yron I; Cohen D; Robinson E; Haber M; Weiss DW
    Cancer Res; 1975 Jul; 35(7):1779-90. PubMed ID: 1093676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized study.
    Ramseur WL; Richards F; Muss HB; Rhyne L; Cooper MR; White DR; Stuart JJ; Spurr CL
    Cancer Treat Rep; 1978 Jul; 62(7):1085-7. PubMed ID: 356970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy in colorectal cancer. (A randomized trial comparing radio-chemotherapy and radio-chemotherapy combined with the methanol extraction residue of BCG, MER).
    Robinson E; Bartal A; Cohen Y; Milstein D; Mekori T
    Biomedicine; 1979 Feb; 31(1):8-10. PubMed ID: 383171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the mouse Lewis tumor by the association of radiotherapy and immunotherapy with Bacillus Calmette-Guérin.
    Dubois JB; Serrou B
    Cancer Res; 1976 May; 36(5):1731-4. PubMed ID: 773530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of cancer.
    Holmes EC; Morton DL; Eilber FR
    West J Med; 1977 Feb; 126(2):102-9. PubMed ID: 322390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary report on the effects of methanol extraction residue of BCG (MER) on cancer patients.
    Robinson E; Bartal A; Cohen Y; Haasz R
    Br J Cancer; 1975 Jul; 32(1):1-4. PubMed ID: 1100088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
    Fisher B; Taylor S; Levine M; Saffer E; Fisher ER
    Cancer Res; 1974 Jul; 34(7):1668-70. PubMed ID: 4599359
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacillus Calmette-Guerin in the treatment of neoplastic disease.
    Laucius JF; Bodurtha AJ; Mastrangelo MJ; Creech RH
    J Reticuloendothel Soc; 1974 Dec; 16(6):347-73. PubMed ID: 4616079
    [No Abstract]   [Full Text] [Related]  

  • 17. Bacillus Calmette-Guerin immunotherapy of the cancer-contaminated wound.
    Lamm DL; Reichert DF; Radwin HM; Thor DE
    J Surg Res; 1979 Jul; 27(1):14-22. PubMed ID: 376948
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of cancer in man.
    Carter SK
    Am Sci; 1976; 64(4):418-23. PubMed ID: 786091
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of immunodeficiency induced by cancer chemotherapy with BCG].
    Miyata T; Masuda H; Inoue T; Saeki K; Torisu M
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):297-300. PubMed ID: 3341790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.